Application Notes

AAV Production – How To Improve Transfection Efficiency and Titer Yield

Exbumin – Stabilizing Virus with Albumin to Improve Yield Application Note

Expansion of Adherent HEK293T Cells in Flasks in Chemically Defined Cell Culture Media

OptiVERO – Formulation of a blood-free and chemically defined virus production media for VERO cells

Blog

Improvement of Vaccine Manufacturing Process with Use of Recombinant HSA Excipient

SARS-CoV2 and Influenza – Double Threat

Solving the Vaccine Supply Challenge

The Emergence of Serum-Free Cell Culture Media – Blood-Free Chemically Defined Components

Interviews

Blood-Free Fetal Bovine Serum Alternatives in Cell Culture Media

Journal Articles (DOI Links)

Improvements in Viral Vector Manufacturing Process with Chemical Definition of Cell Culture Media & Excipients

Posters

Chemically Defined iCELLis® Bioreactor-Based Lentiviral Vector Mass Production

Chemically Defined iCELLis® Bioreactor-Based Viral Vector Manufacturing – Application of Aber Biomass Probes to Inform Transfection Timing

Improving Vaccine Development, Performance, and Stability with Recombinant HSA Excipient

Product Brochures

2021 Product Catalog

ITSE AF – Brochure

Optiferrin – Product Brochure

Product Specifications

ITS – Specifications

ITSE+A – Specifications

SDS

Exbumin – Safety Data Sheet

ITSE AF – Safety Data Sheet

Use Guidelines

Exbumin – Guidelines for Use

ITS – Guidelines for Use

ITSE AF – Guidelines for Use

ITSE+A – Guidelines for Use

Webinar

Accelerating Vaccine Development Through Use of Blood-Free Components

White Papers

Cellastim S – Recombinant Human Serum Albumin in the Generation of Functional Cardiomyocytes from Pluripotent Stem Cells

Emergence of Blood-Free Recombinant Human Albumin

Formulation and production of a blood‐free and chemically defined virus production media for VERO cells

Optimization of Albumin Inclusion in Cell Culture Media – Fatty Acid Profiles